Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-14
DOI
10.1038/s41598-020-78828-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDL (High-Density Lipoprotein) Metrics and Atherosclerotic Risk in Women
- (2018) Samar R. El Khoudary et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Management of residual risk after statin therapy
- (2016) Christina Reith et al. ATHEROSCLEROSIS
- Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction
- (2016) Cheol Hyun Lee et al. MEDICINE
- Determinants for Achieving the LDL-C Target of Lipid Control for Secondary Prevention of Cardiovascular Events in Taiwan
- (2015) Li-Ting Ho et al. PLoS One
- Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk
- (2013) Haseeb Jafri et al. ANNALS OF INTERNAL MEDICINE
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)
- (2011) Lawrence A. Leiter et al. CANADIAN JOURNAL OF CARDIOLOGY
- Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease
- (2011) Rachel R. Huxley et al. CIRCULATION
- HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
- (2010) Paul M Ridker et al. LANCET
- Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes
- (2009) Kausik K. Ray et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
- (2009) Philip J. Barter et al. JOURNAL OF LIPID RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started